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The role of CD4 T cells in the pathogenesis of ocular toxoplasmosis was investigated in murine models
utilizing inbred C57BL/6 mice deficient either in CD4, CD8, or B cells (MT). Severe necrosis and
inflammation with replicating parasites were observed in the eyes of control mice after primary ocular
infection, and near-normal histology with few tachyzoites was observed in the eyes of mice immunized
intraperitoneally with the avirulent ts-4 strain followed by intraocular challenge with the RH strain of
Toxoplasma gondii. In contrast, mild inflammation without evidence of necrosis associated with increased
parasite burdens were observed in the eyes of CD4 knockout (KO) mice after both primary ocular infection and
challenge with RH tachyzoites. CD8 KO mice, as well as MT mice, demonstrated increased ocular necrosis
in response to either primary ocular infection or challenge. The parasite burden was increased in the eyes of
both CD8 KO and MT mice in which the parasite load was even higher. As expected, there were no increases
in the levels of immunoglobulin G in serum or aqueous humor in MT mice, and there was no increase in the
levels of gamma interferon and tumor necrosis factor alpha in the sera of CD4 KO mice after both infection
and challenge. These results suggest that the ocular inflammatory response to the parasite is mediated
primarily by the CD4-T-cell response. CD8 T cells and B cells may play an important role in limiting
tachyzoite proliferation in the eyes. Mice deficient in CD8 CD4 T cells or B cells exhibit diminished
vaccine-induced resistance and increased ocular parasite burden after challenge.
Toxoplasma gondii is an obligate intracellular protozoan par-
asite occurring worldwide in humans and animals. Under nor-
mal conditions, this infection is largely asymptomatic, but in
immunocompromised individuals such as patients with AIDS
the parasite is no longer contained by the host immune re-
sponse, resulting in the development of toxoplasmic encepha-
litis (15). T. gondii is also an important cause of ocular disease
in both immunosuppressed and immunocompetent individuals
and is the most common cause of infectious retinochoroiditis
in otherwise-healthy individuals (30). Ocular toxoplasmosis
(OT), a potentially blinding disorder, is the most common
cause of human retinochoroiditis worldwide (9). About 1 to
3% of AIDS patients will develop OT during the course of
their illness (28).
The host immune response against T. gondii can be an innate
acute response or an antigen-specific cell-mediated immune
response. Cell-mediated immunity is essential for protection
against T. gondii (8). Gamma interferon (IFN-)-dependent,
cell-mediated immunity plays the major role in resistance to
toxoplasmic encephalitis (35). The role of CD4 T cells in the
immunopathogenesis of systemic infection with T. gondii is well
appreciated (21). In C57BL/6 mice, necrosis of the small in-
testine after peroral infection with T. gondii is CD4 T cell
dependent and IFN- mediated (21).
The pathogenesis of many major infectious diseases of the
eye, including onchocerciasis (26), herpes simplex virus kera-
titis (38), trachoma (1), and pseudomonal keratitis (16), is in
part immune mediated. OT may also be considered an im-
mune-mediated process. Previous studies from our laboratory
and others have demonstrated the importance of cell-mediated
immune response and specific cytokines in this process in T.
gondii ocular infection (7, 22). Feron et al. (6) reported that T.
gondii-specific T cells in vitreous fluid from patients involve the
local inflammatory response of OT. However, the specific
function of the T-cell responses in the process of immuno-
pathogenesis of this condition is not fully understood. Because
some aspects of the mouse model mimic the aspects of the
disease in the eyes of human patients, the present study was
designed to better understand the role of CD4 T cells in the
immunopathogenesis of OT by using experimental murine
models deficient in CD4 CD8 T cells and B cells.
MATERIALS AND METHODS
Parasites. The RH strain of T. gondii and the temperature-sensitive mutant of
RH T. gondii strain (ts-4; kindly provided by Elmer Pfefferkorn, Dartmouth
Medical School, Lebanon, N.H.) were used in the present study. In some exper-
iments, RH strain tachyzoites engineered to constitutively express green fluores-
cent protein (GFP; RH-GFP [kindly provided by John Boothroyd, Stanford
University, Stanford, Calif.]) were used. They were maintained by continuous
passage in human fibroblasts grown in Dulbecco modified Eagle medium (cat-
alog no. 11965; Gibco, Grand Island, N.Y.) supplemented with 10% newborn calf
serum plus antibiotics.
Mice. A breeding pair of CD8 knockout (KO) mice on a C57BL/6 background
was kindly provided by T. W. Mak (Amgen Institute, Toronto, Ontario, Canada).
Age-matched (7- to 9-week-old) and sex-matched C57BL/6 wild-type (WT), CD4
KO, and B-cell-deficient (MT) mice of the same genetic background were
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obtained from The Jackson Laboratory (Bar Harbor, Maine). Animals were bred
under specific-pathogen-free conditions at the Animal Research Facility at Dart-
mouth Medical School.
Immunization and eye inoculation. Mice were immunized by intraperitoneal
(i.p.) injection of 105 ts-4 strain tachyzoites as previously reported (22). CD4 KO,
MT, and WT mice were challenged by eye inoculation of 100 RH tachyzoites
at 28 days postimmunization, and CD8 KO mice were challenged at 15 days
postimmunization. Primary infection of naive mice was performed by ocular
inoculation with 100 RH tachyzoites. Eye inoculation was performed as previ-
ously described (12). Briefly, mice were anesthetized with ketamine hydrochlo-
ride (40 mg/kg) and xylazine (5 mg/kg) by i.p. injection. After the leaking
aqueous fluid was blotted on the right eye, a 5-l parasite suspension in Dul-
becco modified Eagle medium was injected into the anterior chamber under an
operating microscope by using a 33-gauge needle attached to a 50-l syringe
(Hamilton, Reno, Nev.).
Histopathology. At 11 days after inoculation, mice were sacrificed by CO2
asphyxiation, and harvested eyes were immediately fixed in 10% buffered form-
aldehyde (Polyscience, Warrington, Pa.). Then, 5-m sections (with a 50- or
100-m distance between sections) of the eye tissue from each mouse were
stained with hematoxylin and eosin and evaluated for inflammatory changes.
Pathological changes were scored on a scale of 0 (normal) to 4 according to the
method of Hu et al. (12) as follows: 0, normal histology; 1, mild inflammation
without necrosis; 2, obvious inflammation without necrosis; 3, strong inflamma-
tion with necrosis; and 4, strong necrosis in whole eye section.
Confocal laser scanning microscopy. Five-m thick sections (50- or 100-m
distance between sections) of paraffin wax-embedded eye tissue from each mouse
infected or challenged with 100 RH-GFP tachyzoites at 11 days were visualized
by using a MRC-1024 confocal scanning laser microscope (Bio-Rad, Hercules,
Calif.) equipped with a Zeiss Axioskop microscope (Oberkochen, Germany), a
40 plan neofluar 1.3 numerical aperture objective lens, and a 15-mW krypton/
argon laser. GFP was detected with a 525 DF32 band-pass filter. The confocal iris
setting was 2.0, and the gain was 845.
Levels of IFN- and TNF- in serum. Mice were bled at 11 days after infection
or challenge, and the serum was collected and stored at 70°C until use. The
levels of IFN- and TNF- in serum were quantitated by enzyme-linked immu-
nosorbent assay kits (Biosource, Camarillo, Calif.) according to the manufactur-
er’s instructions. Optical density (OD) values were measured at 450 nm, and the
cytokine concentrations in serum were determined from the standard curve.
Anti-toxoplasma antibody levels in serum and aqueous fluid. Approximately
10 to 15 l of aqueous fluid was withdrawn by using a 27.5-gauge needle via a
limbal paracentesis from each naive mouse, and each mouse was immunized i.p.
with ts-4 at 28 days. The fluid was stored at 70°C until use. Purified RH
parasites (5  104/well) were placed in microtiter plates (Nunc-Immuno Plate;
Nunc, Roskilde, Denmark), dried overnight, blocked with 5% bovine serum
albumin–phosphate-buffered saline (PBS) (Sigma, St. Louis, Mo.), and washed in
PBS (pH 7.2)–0.05% Tween 20 (Bio-Rad). Antisera and aqueous fluid were
incubated for 2 h at 37°C. Plates were washed and supplemented with a perox-
idase-conjugated rabbit anti-mouse immunoglobulin G (IgG; whole molecule,
1/40,000; Sigma) for 1 h. After a wash step, tetramethyl benzidine substrate in
H2O2 (Kirkegaard Perry, Gaithersburg, Md.) was used for development. The
reaction was stopped 30 min later by the addition of 2 N H2SO4. OD values were
measured at 450 nm with an automatic microplate reader (model 550; Bio-Rad).
Statistical analysis. Data were analyzed by using the Student t test or the
Wilcoxon signed rank test. P values of 0.05 were considered statistically sig-
nificant.
RESULTS
Decreased ocular inflammation in CD4-T-cell-deficient
mice. Histological changes (Fig. 1) and inflammatory scores
(Table 1) in the eye tissues of genetically deficient and control
mice were compared after primary intraocular infection with
100 RH strain tachyzoites or immunization with the ts-4 avir-
ulent parasite strain, followed by challenge with 100 RH
tachyzoites at 11 days. In control mice, severe inflammation
and necrosis were observed in the eye tissue after primary
infection (Fig. 1A). Vaccination with the ts-4 strain protected
the eye tissue from necrosis after intraocular challenge (Fig.
1B). Primary ocular parasite infection of MT mice resulted in
increased inflammation and necrosis (Fig. 1C), and the inflam-
matory score significantly increased (P  0.043). Vaccination
with ts-4, followed by ocular challenge, did not protect MT
from inflammation and necrosis of the eye tissue (Fig. 1D) (P
 0.028). In CD8 KO mice, increased inflammation and ne-
crosis were observed in the eye tissue after either primary
ocular infection (Fig. 1G) (P  0.043) or vaccination, followed
by challenge (Fig. 1H) (P  0.028). In CD4 KO mice, only mild
inflammatory cellular infiltration was observed in the eye tissue
after primary infection (Fig. 1E) (P  0.043) and without
histological evidence of ocular inflammation or necrosis after
vaccination with ts-4, followed by RH strain challenge (Fig.
1F).
Increased ocular parasite burden in CD4-T-cell-deficient
mice. Parasite proliferation in the eye tissues from mutant and
control mice was evaluated by confocal microscopy at 11 days
after primary infection with 100 RH-GFP tachyzoites or ts-4
immunization, followed by challenge with 100 RH-GFP
tachyzoites. As shown in Fig. 2, a quantitative increase in
parasite burden was observed after primary infection (Fig. 2A),
whereas few parasites were seen after ts-4 vaccination and
challenge (Fig. 2B) in the eye tissues of control mice. In con-
trast, an increased parasite burden was observed after primary
infection (Fig. 2E), as well as ts-4 vaccination and challenge
(Fig. 2F), in the eye tissues of CD4 KO mice. An increased
parasite burden was also observed in the eye tissues of CD8
KO mice after either primary infection (Fig. 2G) or ts-4 vac-
cination and challenge (Fig. 2H). However, the greatest in-
creased parasite burdens were observed in the eye tissues of
MT mice after either primary ocular infection (Fig. 2C) or
ts-4 vaccination and challenge (Fig. 2D), suggesting a potential
role for antibody production in control of ocular parasite bur-
den.
Parasite numbers in the eye tissue of the strains of mice were
quantified. Eyes were isolated at 11 days after primary intraoc-
ular infection or ts-4 vaccination and challenge with 100 RH-
TABLE 1. Comparison of parasite numbers and inflammatory
scores in the eyes of control and mutant mice after primary
infection or ts-4 vaccination and challenge with T. gondiia
Mouse group









Control 2,2,3,3,3,3 1,0,1,1,1,0 3.00 	 0.42** 0.30 	 0.11**
B KO 3,3,3,4,4 2,2,2,2,2 12.13 	 2.13** 5.43 	 1.55**
CD8 KO 3,3,4,4,3,4 2,2,3,4,3,3 4.34 	 0.71** 3.59 	 0.43**
CD4 KO 1,0,1,1,1 1,1,0,1,1 3.65 	 0.50* 3.22 	 0.50**
a Mice were infected or ts-4 vaccinated and challenged intracamerally with 100
RH tachyzoites, and the inflammatory scores and parasite numbers in their eyes
were examined at day 11. The details of this experiment are described in the text.
Compared to controls (n  6), MT mice (n  5) had significantly increased
inflammation and necrosis in the eye tissue after primary infection (P  0.043)
and vaccination with ts-4, followed by ocular challenge (P  0.028). CD8 KO
mice (n  6) had significantly increased inflammation and necrosis after either
primary ocular infection (P  0.043) or vaccination, followed by challenge (P 
0.028). CD4 KO mice (n  5) had only mild inflammatory cellular infiltration in
the eye tissue after infection (P  0.043) and without histologic evidence of
ocular inflammation after challenge. For parasite numbers, each value represents
the mean of four mice 	 the standard error. Similar results were obtained in two
experiments. *, P  0.05; **, P  0.01 (compared to control).
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GFP tachyzoites. The eye tissue was teased apart, passed
through a stainless steel mesh, and incubated with monolayers
of human fibroblasts in 25-cm2 flasks at 37°C for 60 h. Parasites
were purified from human fibroblast cell culture as previously
described (11) and were counted by hemocytometer from four
mice in each group (Table 1). Compared to controls, ocular
tissue from MT mice demonstrated the greatest numbers of
parasites (106/ml) after either primary infection (P  0.01) or
ts-4 vaccination followed by challenge (P  0.01). Parasite
numbers from the ocular tissue of CD8 KO mice were in-
creased after either primary infection (P  0.01) or vaccination
followed by challenge (P  0.01). Increased parasite numbers
were also observed in the eyes of CD4 KO mice after either
primary infection (P  0.05) or ts-4 vaccination followed by
challenge (P  0.01).
FIG. 1. Pathology of eye tissues from mutant and control mice
infected or challenged intracamerally with 100 RH strain T. gondii
tachyzoites at 11 days. Shown are the eyes of an infected (A) and
challenged (B) control mouse, an infected (C) and challenged
(D) MT mouse, an infected (E) and challenged (F) CD4 KO mouse,
an infected (G) and challenged (H) CD8 KO mouse, a normal naive
mouse (I), and a normal CD8 KO mouse (J). Six mice were used in
each group; this experiment is representative of two performed. Mag-
nification, 4. Hematoxylin and eosin stain was used.
FIG. 2. Parasite replication in the eye tissues of mutant and control
mice infected or challenged intracamerally with 100 tachyzoites of
RH-GFP at 11 days. Shown are the eyes of an infected (A) and
challenged (B) control mouse, an infected (C) and challenged
(D) MT mouse, an infected (E) and challenged (F) CD4 KO mouse,
and an infected (G) and challenged (H) CD8 KO mouse. Six mice were
used in each group; this experiment is representative of two per-
formed.
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Levels of IFN- and TNF- in serum. Compared to day 0,
there were significant increases of serum levels of IFN- and
TNF- in control, MT, and CD8 KO mice at 11 days after
either primary ocular infection (P  0.01) or ts-4 vaccination
and challenge (P  0.01). However, the levels of IFN- and
TNF- in serum were not significantly different in CD4 KO
mice after either ocular infection or challenge (Fig. 3).
Anti-toxoplasma antibody level. Compared to day 0, the
levels of IgG (i.e. the OD value) in serum were significantly
increased in control and CD8 KO mice at 11 days after both
primary infection (P  0.05) and vaccination with challenge (P
 0.01). Anti-toxoplasma IgG titers were 1:3,200 to 1:6,400
after infection and 1:12,800 to 1:51,200 after challenge. In CD4
KO mice, the IgG level in serum was significantly increased
after challenge (P  0.01) but not after primary infection.
However, anti-toxoplasma antibody level was not detectable in
the sera of MT mice (Fig. 4A). At day 28 after i.p. immuni-
zation with ts-4, the levels of IgG in the eye fluid from control,
CD4 KO, and CD8 KO mice were all significantly increased (P
 0.01) but not in MT mice (Fig. 4B).
DISCUSSION
The eye is an immunologically privileged site, and the patho-
genesis of OT is complex and as yet poorly understood. We
used C57BL/6 background CD4-T-cell-deficient, CD8-T-
cell-deficient, and MT murine models to investigate the roles
of these cells in the development of pathogenesis of acute OT
and in the protective immunity against ocular infection of RH
strain tachyzoites of T. gondii. Our data indicate that CD4 T
cells are essential to the pathogenesis of OT.
CD4 T cells are important in the inflammatory cell re-
sponse against acute T. gondii infection. In the present study,
we observed that eyes from CD4 KO mice did not show ne-
crosis or acute inflammation after either primary infection or
ts-4 vaccination and challenge. Experiments using anti-CD4
treatment or class II-deficient C57BL/6 mice by Liesenfeld et
al. (21) support a role for CD4 T cells in determining disease
outcome and the development of this inflammatory process in
the small intestine. Our data demonstrate that CD4 T cells
are required for the induction of ocular pathogenesis. In ad-
dition, we observed that, compared to controls, the number of
parasites was much higher in the eyes of CD4 KO mice after
either primary infection or vaccination and challenge. CD4-
T-cell depletion not only influences the development of brain
cyst in infected mice (4) but also results in a significant increase
in the number of brain cysts in vaccinated mice (33). CD4 T
cells have an important role in the maintenance of CD8-T-
cell immunity against T. gondii (4). CD4 T cells provide a
helper function necessary for the generation and/or activity of
CD8 effector cells and for the induction of both protection
and CD8 functional activity (8, 24). Depletion of both CD4
and CD8 cells has a greater effect on resistance than the
depletion of CD8 cells alone (8). Feron et al. (6) found that
all T. gondii-specific T-cell clones isolated from the vitreous
fluid of patients with OT are CD3 CD4 T cells. Our results
indicate that CD4 T cells play an important role in complete
protective immunity against T. gondii challenge and participate
in parasite reduction during ocular infection.
The importance of CD8 T cells in the host systemic re-
sponse to this parasite is well appreciated (8). Compared to
controls, we observed more severe necrosis with greater mul-
tiplication of tachyzoites in the eyes of CD8 KO mice after
either primary ocular infection or vaccination with ts-4 and
challenge. Depletion of CD8 T cells significantly decreases
both passive immunity and active resistance to lethal infection
of T. gondii (8, 37) and, in addition, reduces the cytotoxic-T-
lymphocyte activity (18). Vaccinated mice depleted of CD8 T
cells are more susceptible to subsequent challenge (37). Brown
and McLeod (3) reported that the formation of cysts of T.
gondii in the brain of mice is mediated by CD8 T cells and
FIG. 3. Levels of IFN- and TNF- in serum. Experiments were performed on mutant and control mice infected or challenged intracamerally
with 100 RH T. gondii tachyzoites at 11 days. Four mice were used in each group; these data are representative of two separate experiments.
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restricted by class I. Treatment with the combination of anti-
CD4 and anti-CD8 monoclonal antibodies results in an in-
crease of cyst numbers in the ocular lesion (7). Our data
indicate that CD8 T cells are involved in parasite control in
both T. gondii-infected and challenged eyes. It has been shown
that CD8 T lymphocytes can lyse extracellular T. gondii
tachyzoites and T. gondii-infected target cells in both humans
and mice in vitro (17, 40). One observation is that the
tachyzoites distributed differently in the eyes between control
and mutant mice, especially in CD8 KO mice. Norose et al.
(25) noted the differences not only in the number of parasites
but also in the distribution of parasites in the various eye parts
between WT and IFN- KO mice. It has also been reported
that OT in immunocompromised host differs from the disease
in immunocompetent patients, both clinically and histopatho-
logically (27).
We observed that, compared to controls, MT mice exhib-
ited more-severe ocular lesions associated with marked in-
creased parasite numbers in the eyes after primary infection, as
well as after vaccination and challenge. This heightened in-
crease in parasite burden in the B-cell-deficient mice suggests
that B-cell function is important in the control of parasite
replication. Antibody is produced systemically and locally in
the eye during ocular infection (39). IgG is the major class
involved in the humoral immune response against T. gondii
parasites (29). B cells are required for vaccination-induced
resistance to virulent tachyzoites to produce antibodies that
function protectively in vivo by blocking the infection of host
cells by tachyzoites (31). T. gondii tachyzoites are rapidly lysed
by the activation of complement through the classical pathway
in vitro in the presence of specific antibodies (32). Antibodies
play a protective role in collaboration with macrophages to kill
antibody-coated tachyzoites in vitro (2), and lymphokine-acti-
vated killer activity enhances in the presence of antibodies
against T. gondii (5). Treatment of tachyzoites with a mono-
clonal antibody to T. gondii inhibits their intracellular prolif-
eration (23). It has been reported that antibodies play a critical
role in prevention of proliferation of tachyzoites in brains and
lungs in both primary infection and reactivation of latent in-
fection (14). Our results demonstrate that B cells are involved
FIG. 4. (A) Levels of anti-toxoplasma IgG in serum. Experiments were performed on mutant and control mice infected or challenged
intracamerally with 100 RH T. gondii tachyzoites at 11 days. (B) Levels of anti-toxoplasma IgG in eye fluid. Samples were collected from mice
vaccinated i.p. with T. gondii ts-4 at 28 days. Four mice were used in each group; these data are representative of two separate experiments.
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in protective immunity against ocular infection and challenge,
and the presence of T. gondii-specific antibodies correlates
with parasite replication in vivo. Consistent with a previous
report (13), we also observed that T. gondii-infected CD4 KO
mice had low IgG levels in serum in acute OT. CD4 helper T
cells may be needed for generation of high titers of isotype-
switched serum antibodies specific for T. gondii antigen (13).
We observed significant increase in the serum production of
IFN- and TNF- in MT, CD8 KO, and control mice at 11
days after both ocular infection and challenge. However, the
production of IFN- and TNF- in CD4 KO mice was not
significantly different after either infection or vaccination and
challenge. T-cell immunity is dependent on the induction of an
effective IFN- and CD8-T-cell response (34); treatment with
either anti-IFN- or anti-TNF- monoclonal antibodies results
in a dramatic increase in the intensity of ocular lesions asso-
ciated with the presence of the parasite and the severity of
inflammatory response (7), whereas IFN- mediates develop-
ment of the immunopathology and contributes to early death
after T. gondii infection (21). Both TNF- and IFN- are
involved in the development of the small intestine pathology
(20). IFN- acts synergistically with TNF- to activate the
inflammatory response and establish the type of immunity that
limits parasite proliferation (19). Our data reveal that whereas
the increased levels of IFN- and TNF- in serum correspond
to the development of ocular necrosis in the infected and
challenged MT, CD8 KO, and control mice, these cytokines
also correspond to the protective role in the challenged control
mice. IFN- is likely produced predominantly by CD4 T cells
(36). Neutralization of either IFN- or CD4 T cells during
peroral infection prevents severe necrosis of the ilea and acute
mortality (21). Our data further suggest that CD4 T cells are
the major source of the production of IFN- and TNF- and
the outcome of ocular pathogenesis.
Host resistance to T. gondii infection is multifaceted and
may involve a number of different cellular and humoral im-
mune responses (10). Our findings suggest that the CD4-T-
cell compartment is fundamental to the induction of inflam-
mation associated with ocular disease. The murine model
utilized in the present study could be applied to better under-
stand the mechanism of trafficking and persistence of these
inflammatory cells in this immune privileged site.
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